A recent study published in Rheumatic and Musculoskeletal Diseases Open has revealed distinct lipid abnormalities in patients with early, treatment-naïve psoriatic arthritis (PsA), shedding light …
The long-term extension (LTE) study DARWIN 3 published in Rheumatic & Musculoskeletal Diseases Open provided significant findings on the safety and efficacy of filgotinib in …
A recent analysis of the SLE Prospective Observational Cohort Study (SPOCS) has provided valuable findings on the real-world treatment patterns and clinical characteristics of patients …
In a groundbreaking development for rheumatology practice, long-term data from the BE AGILE clinical trial and its open-label extension published IN Rheumatic & Musculoskeletal Diseases …
A recent study published in Rheumatology and Immunology Research has highlighted the potential role of serum 14-3-3 Eta protein as a novel biomarker for the …
A recent double-blind, randomized, placebo-controlled study published in Joint Diseases and Related Surgery has highlighted the potential benefits of collagen supplementation in managing osteoarthritis (OA)-related …
A nationwide observational study from Spain published in Medicina Clínica has highlighted a significantly higher mortality risk from lung and hematologic neoplasms in patients with …
A recent phase II clinical trial published in Rheumatic and Musculoskeletal Diseases has revealed promising outcomes for jaktinib hydrochloride, a Janus kinase inhibitor (JAK) , …
The phase 3 BLISS-BELIEVE trial provided valuable insights into the efficacy and safety of sequential therapy with subcutaneous belimumab (BEL) and a single cycle of …